melitten has been researched along with calmidazolium* in 5 studies
5 other study(ies) available for melitten and calmidazolium
Article | Year |
---|---|
Primary structure, expression and developmental regulation of a Dictyostelium calcineurin A homologue.
cDNA clones for the catalytic subunit of Ca2+/calmodulin(CaM)-dependent protein phosphatase (calcineurin A, protein phosphatase 2B) from Dictyostelium discoideum were isolated by functional screening of a lambda gt11 lysogen expression library with labeled Dictyostelium CaM. A complete cDNA of 2146 bp predicts a protein of 623 amino acids with homology to calcineurin A from other organisms and a similar molecular architecture. However, the Dictyostelium protein contains N-terminal and C-terminal extra domains causing a significantly higher molecular mass than found in any of its known counterparts. Recombinant Dictyostelium calcineurin A was purified from Escherichia coli cells and shown to display similar enzymatic properties as the enzyme from other sources. On Western blots specific antibodies against the protein recognized a band of approximately 80 kDa that migrated with an endogenous CaM-binding activity. Both the mRNA for calcineurin A and the protein are expressed during the growth phase. During early development the abundance of the protein is reduced and then increases to peak after 10 h of starvation, when tight aggregates have formed. Topics: Amino Acid Sequence; Animals; Antibodies; Base Sequence; Blotting, Western; Calcineurin; Calcium; Calmodulin; Calmodulin-Binding Proteins; Chromatography, Affinity; Cloning, Molecular; Dictyostelium; DNA, Complementary; Enzyme Inhibitors; Escherichia coli; Gene Expression Regulation, Developmental; Imidazoles; Melitten; Molecular Sequence Data; Phosphoprotein Phosphatases; Recombinant Proteins; Sequence Alignment; Sequence Analysis | 1996 |
Effects of various calmodulin antagonists on Na/Ca exchange current of single ventricular cells of guinea-pig.
The effects of various calmodulin inhibitors were examined on the Na/Ca exchange current in single cardiac ventricular cells of the guinea-pig using the whole-cell patch-clamp technique. External application of W-7 and trifluoperazine inhibited Na/Ca exchange current in a dose-dependent manner with IC50 values of 13 and 7 microM, respectively. W-5 inhibited the exchange current but less potently than W-7. More specific calmodulin inhibitors such as CGS 9343B and calmidazolium did not, however, decrease the current as significantly as expected. All these drugs inhibited the Na current more strongly than the Na/Ca exchange current. Ruthenium red (RR), another type of calmodulin inhibitor, did not decrease the exchange current by internal application. Neither mastoparan or melittin (calmodulin-binding peptides) inhibited the exchange current appreciably. RR and the peptides did not affect the Na current either. These results indicate that calmodulin may not involved in the activation of cardiac Na/Ca exchange or the Na current. Internal application of chymotrypsin inhibited the blocking effect of W-7 on the Na/Ca exchange current but not that on the Na current. These results indicate that W-7 blocks the Na/Ca exchange current not by binding to calmodulin but possibly by directly affecting an internal site of the exchanger itself and that the inhibitory action of W-7 is different on the Na/Ca exchange current and the Na current. Topics: Animals; Benzimidazoles; Calcium; Calmodulin; Carrier Proteins; Guinea Pigs; Heart Ventricles; Imidazoles; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Melitten; Myocardium; Peptides; Ruthenium Red; Sodium; Sodium-Calcium Exchanger; Sulfonamides; Trifluoperazine; Wasp Venoms | 1993 |
Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin.
We investigated whether calmodulin mediates the stimulating effect of Ca2+ on nitric oxide synthase in the cytosol of porcine aortic endothelial cells. Nitric oxide was quantified by activation of a purified soluble guanylate cyclase. The Ca2(+)-sensitivity of nitric oxide synthase was lost after anion exchange chromatography of the endothelial cytosol and could only be reconstituted by addition of calmodulin or heat-denatured endothelial cytosol. The Ca2(+)-dependent activation of nitric oxide synthase in the cytosol was inhibited by the calmodulin-binding peptides/proteins melittin, mastoparan, and calcineurin (IC50 450, 350 and 60 nM, respectively), but not by the calmodulin antagonist, calmidazolium. In contrast, Ca2(+)-calmodulin-reconstituted nitric oxide synthase was inhibited with similar potency by melittin and calmidazolium. The results suggest that the Ca2(+)-dependent activation of nitric oxide synthase in endothelial cells is mediated by calmodulin. Topics: Amino Acid Oxidoreductases; Animals; Calcineurin; Calcium; Calmodulin; Calmodulin-Binding Proteins; Cells, Cultured; Cytosol; Endothelium, Vascular; Enzyme Activation; Guanylate Cyclase; Imidazoles; Intercellular Signaling Peptides and Proteins; Kinetics; Melitten; Nitric Oxide; Nitric Oxide Synthase; Peptides; Phosphoprotein Phosphatases; Swine; Wasp Venoms | 1990 |
Calmodulin and protein kinase C antagonists also inhibit the Ca2+-dependent protein protease, calpain I.
The calmodulin and C-kinase antagonists melittin, calmidazolium, N-(6-aminohexyl)-5-chloro-1-napthalenesulfonamide (W7), and trifluoperazine (TFP) also inhibit the activity of the human erythrocyte Ca2+-dependent protease, calpain I. W-5, the nonchlorinated derivative of W-7, was ineffective as an inhibitor of calpain I just as it is for calmodulin and protein kinase C. Dose response studies provided the following IC50 values: melittin, 2.6 microM; calmidazolium, 6.2 microM; trifluoperazine, 130 microM; W-7, 251 microM. These IC50 values indicate that the compounds have affinities 10 to 600 fold less for calpain I than for calmodulin; however, the affinities of the inhibitory compounds are comparable for calpain I and protein kinase C. Kinetic analysis indicates that the compounds are competitive inhibitors of calpain I with respect to substrate. Topics: Bee Venoms; Calmodulin; Calpain; Erythrocytes; Humans; Imidazoles; Kinetics; Melitten; Protein Kinase C; Sulfonamides; Trifluoperazine | 1989 |
Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin.
We evaluated the effect of several classes of calmodulin inhibitors on the activity of calmodulin prepared from C6 astrocytoma cells and studied the activity of these drugs as inhibitors of the growth of C6 cells in tissue culture. There was a good correlation between the activity of the drugs as inhibitors of calmodulin and their activity as inhibitors of cell growth. The most potent compounds were calmidazolium and melittin as compared to the phenothiazines, trifluoperazine, chlorpromazine, chlorpromazine-sulfoxide or the diphenylbutylpiperidine, pimozide. The mechanism by which the inhibition of calmodulin leads to the death of cells could not be attributed entirely to inhibition of the calmodulin-sensitive cyclic nucleotide phosphodiesterase. Calmodulin is a heat stable, calcium-binding protein involved in numerous biological processes. Recent evidence indicates that calcium and calmodulin may be important for cellular proliferation. For example, this protein changes in concentration during the cell cycle; is involved in the disassembly of the mitotic apparatus; is increased in concentration in rapidly growing hepatomas and in transformed fibroblasts. Weiss and co-workers demonstrated that phenothiazines and structurally similar drugs are capable of binding to and inhibiting the activity of calmodulin. It has been recently observed that certain drugs that inhibit the activity of calmodulin also inhibit the growth of malignant cells in vitro and in vivo. In these studies, however, there was no direct correlation of the effect of the drugs on the calmodulin from the cell type under investigation with cytotoxicity. To learn more about the relationship between a drug's ability to inhibit calmodulin and its antiproliferative activity, we correlated the effect of drugs on the activity of calmodulin prepared from the C6 astrocytoma cell line with their effect on cellular proliferation. Since many inhibitors of calmodulin readily cross the blood-brain barrier and since no acceptable treatment for malignancies of the central nervous system exist, we chose this cell line as a model for elucidating the potential antineoplastic effects of calmodulin inhibitors. Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Astrocytoma; Calmodulin; Cell Division; Cell Line; Chlorpromazine; Imidazoles; Melitten; Pimozide; Rats; Structure-Activity Relationship; Trifluoperazine | 1985 |